<p>Chronic Venous Insufficiency (CVI) is a progressive condition characterized by impaired blood flow in the veins of the lower extremities due to damaged or weakened vein walls or valves. This leads to pooling of blood, swelling, and complications such as varicose veins, leg ulcers, and skin changes. CVI is often linked to risk factors like prolonged standing or sitting, obesity, pregnancy, aging, and a family history of venous disease. Symptoms vary by severity but commonly include leg pain, swelling, heaviness, and cramping. Early diagnosis and timely intervention are crucial to preventing disease progression and enhancing patient outcomes.</p>
<h2><strong>Chronic Venous Insufficiency Epidemiological Segmentation</strong></h2>
<p>The Epidemiological Segmentation of Chronic Venous Insufficiency in the 7MM from 2020 to 2034 includes:</p>
<ul>
<li>Total Prevalent Cases</li>
<li>Gender-specific Cases</li>
<li>Age-specific Cases</li>
<li>Treatable Cases</li>
</ul>
<h2><a href="https://www.delveinsight.com/report-store/chronic-venous-insufficiency-epidemiology-forecast"><span style="text-decoration: underline;"><strong>Chronic Venous Insufficiency Epidemiology</strong></span></a></h2>
<p>In 2023, the total prevalent cases of Chronic Venous Disease (CVD) in the 7MM were approximately 463 million.</p>
<ul>
<li>The US accounted for 6.2 million prevalent cases of Chronic Venous Insufficiency (CVI) in 2023.</li>
<li>Among the stages, C1 stage had the highest diagnosed prevalence in the US.</li>
<li>Gender-specific and age-specific prevalence trends show a higher incidence in females and older populations, consistent with the progressive nature of the disease.</li>
</ul>
<h2><a href="https://www.delveinsight.com/report-store/chronic-venous-insufficiency-market"><span style="text-decoration: underline;"><strong>Chronic Venous Insufficiency Market</strong></span></a></h2>
<p>The Chronic Venous Insufficiency (CVI) market size in the 7MM was valued at approximately USD 2 billion in 2023.</p>
<h2>Chronic Venous Insufficiency Market Drivers</h2>
<ul>
<li>Growing awareness of CVI and its complications has fueled the demand for advanced diagnostic tools and therapeutic devices.</li>
<li>Continuous innovation in minimally invasive treatment options, including endovenous therapies and novel devices, is transforming patient care.</li>
</ul>
<h2>Chronic Venous Insufficiency Market Barriers</h2>
<ul>
<li>High costs associated with advanced therapies and devices can limit access, particularly in regions with underfunded healthcare systems.</li>
<li>Patient adherence to lifestyle modifications and compression therapy remains a significant challenge in disease management.</li>
</ul>
<h2><a href="https://www.delveinsight.com/report-store/chronic-venous-insufficiency-pipeline-insight"><span style="text-decoration: underline;"><strong>Chronic Venous Insufficiency Emerging Devices</strong></span></a></h2>
<ul>
<li>VenoValve</li>
<li>EnVVe</li>
<li>SONOVEIN</li>
</ul>
<p>And others</p>
<h2><strong>Chronic Venous Insufficiency Key Players</strong></h2>
<ul>
<li>Philips</li>
<li>BD</li>
<li>Medtronic</li>
<li>Tactile Medical</li>
<li>Koya Medical</li>
<li>Verigraft AB</li>
<li>enVVeno Medical Corporation</li>
<li>Theraclion</li>
</ul>
<p>And others</p>

Chronic Venous Insufficiency Market Infographic

Chronic Venous Insufficiency Infographic

Chronic Venous Insufficiency Symptoms, Treatment, epidemiology, companies, drugs infographic is a short guide to understand the problem and market landscape.